NCT03787602 · Interventional trial
Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma
Overall registry status Unknown
Phase 1 · Phase 2
Conditions Merkel Cell Carcinoma
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County · Active not recruiting
First posted
Registry updated
Added to the directory